MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $261,225 | -10.8% | 900 | -69.8% | 0.00% | 0.0% |
Q1 2022 | $293,000 | -33.3% | 2,982 | -42.5% | 0.00% | 0.0% |
Q4 2021 | $439,000 | -84.6% | 5,182 | -85.5% | 0.00% | -85.7% |
Q3 2021 | $2,844,000 | -65.6% | 35,640 | -58.0% | 0.01% | -68.2% |
Q2 2021 | $8,274,000 | -38.9% | 84,940 | -26.7% | 0.02% | -40.5% |
Q1 2021 | $13,550,000 | +208.2% | 115,840 | +193.0% | 0.04% | +208.3% |
Q4 2020 | $4,396,000 | +99.7% | 39,540 | +113.3% | 0.01% | +100.0% |
Q3 2020 | $2,201,000 | +59.4% | 18,540 | +52.0% | 0.01% | +50.0% |
Q2 2020 | $1,381,000 | -37.8% | 12,198 | -38.1% | 0.00% | -33.3% |
Q4 2018 | $2,220,000 | +31.1% | 19,698 | +149.1% | 0.01% | +50.0% |
Q3 2018 | $1,694,000 | -16.0% | 7,909 | +9.7% | 0.00% | -20.0% |
Q2 2018 | $2,016,000 | +153.6% | 7,209 | +5.9% | 0.01% | +150.0% |
Q1 2018 | $795,000 | – | 6,809 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |